Kyowa Pharmaceutical Industry

Rediff.com » News » Kyowa Pharmaceutical Industry

News for Kyowa Pharmaceutical Industry

Business

Lupin aims to enter Chinese market in the next one year

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time. Mumbai-headquartered Lupin is firming up plans to......

Lupin sells Japan arm to Unison for Rs 3,702 cr

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India. Pharma major Lupin has divested its entire stake in its Japanese subsidiary,......

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally. Kyowa Pharmaceutical Industry, drug major Lupin's Japanese subsidiary, has......

India-Japan pact hangs in balance over pharma exports

Talks to expand India-Japan trade pact remain a work in progress, even as trade deficit with Japan widens, says Nayanima Basu.The much-awaited review of the India-Japan comprehensive economic......

Pharma firms eye small buys to stay fit

Dr Reddy's Laboratories, Nicholas Piramal and other Indian drug makers are relying on niche and smaller value, acquisition strategy for growth owing to global slowdown and failure of big-ticket......

Rediff News

Kyowa Pharmaceutical Industry

News for Kyowa Pharmaceutical Industry

Lupin aims to enter Chinese market in the next one year

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

India-Japan pact hangs in balance over pharma exports

Pharma firms eye small buys to stay fit

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS